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Introduction
The development of novel receptors for anionic species has been an area of active research within the field of supramolecular chemistry in the last decade (1) . Anion receptors have been applied in a wide range of areas such as anion sensing, anion extraction, anion transport through lipid bilayers and organocatalysis (2) . Particular effort has been devoted to the development of receptors for biologically relevant anions such as chloride, fluoride, acetate or phosphates (3) .
In recent years, we have focused on the development of receptors for the pyrophosphate anion (P 2 O 7 4− , PPi) which is formed by the hydrolysis of adenosine triphosphate (ATP) in cells and as such, plays an important role in a range of metabolic processes (4) . We have reported a number of cyclic peptide-based scaffolds with two pendant zinc(II)dipicolylamine (Zn(II)-DPA) arms which were installed via the reductive amination (RA) of free amine side chain functionalities, with subsequent complexation of the DPA unit to zinc(II) (5) . Utilising indicator displacement assays (IDAs) (6) , we have shown that these cyclic receptors were able to selectively recognise PPi in the presence of other inorganic and organic phosphates such as hydrogen phosphate and ATP in aqueous and physiological media (HEPES and Krebs buffer) (5) . Subsequently, we created a small library of synthetically facile linear peptide-based Zn(II)-DPA-functionalised receptors for the recognition of PPi (7) . The pendant Zn(II)-DPA binding sites were again incorpo-rated through the RA reaction. Despite their lack of preorganisation compared to the cyclic peptide derived analogues, these novel linear peptide-based scaffolds displayed high affinity and selectivity for PPi (7) .
The copper(I)-catalysed azide-alkyne [3 + 2] cycloaddition (CuAAC) is a well-known, high yielding, reliable and widely used reaction ('click reaction') for the covalent connection of an alkyne and an azide building block (8) ; moreover, the CuAAC has been found to be fully compatible with SPPS (9) . We wished to utilise the CuAAC for the attachment of the DPA unit to our linear peptide-based scaffolds on solid phase, as this would connect the DPA moiety to the scaffold through a [1, 2, 3] -triazole linker (as compared to an alkyl chain which is the resulting linker when we install the DPA units via RA, Figure 1 ) and it has previously been established that a ligand containing a triazole connected to a DPA unit via a short spacer coordinates zinc(II) ions in a tetradentate manner (10) . We hypothesised that the incorporation of an additional metal binding site might influence the anion-binding properties of the receptor.
Herein, we report the novel synthesis of triazole-containing linear peptide-based receptors 1.Zn 2 and 2.Zn 2 (Figure 2 ). We prepared both of these diastereomers as it has previously been found that the relative stereochemistry of the amino acid side chains has an effect on anion binding affinity and selectivity (7) . The synthetic approach to receptor precursors 1 and 2 was designed such that it could be entirely performed on solid phase. Furthermore, we test our hypothesis that the triazole lin-ker affects the binding properties of our receptors to PPi by conducting anion-binding studies using colorimetric IDAs in Krebs buffer (a physiological medium that is commonly used for cell and tissue culture and is approximately isotonic with blood serum) (5, 6) . Analogous receptors 3.Zn 2 and 4.Zn 2 which lack the triazole moiety were synthesised and then tested under identical conditions as receptors 1.Zn 2 and 2.Zn 2 to allow a direct comparison of anion-binding abilities.
Results and discussion

Synthesis of receptors
The synthesis of receptors 1.Zn 2 and 2.Zn 2 was carried out using a 9-fluorenylmethoxycarbonyl solid-phase peptide synthesis (Fmoc-SPPS) strategy on Rink amide resin using (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) as the coupling reagent (Scheme 1). We incorporated a C-terminal Gly residue as we have previously found that a Gly spacer between the peptide and the bulky resin facilitates the on-resin RA reaction to install the DPA units (7) and we anticipated that this would also be the case for the planned on-resin CuAAC reaction.
Initial Fmoc deprotection of Rink amide resin was achieved using 20% piperidine in DMF and loading was performed by treatment with Fmoc-Gly-OH in the presence of PyBOP and N,N-diisopropylethylamine (DIPEA). Iterative Fmoc deprotection and coupling of Fmocpropargylglycine (Fmoc-L-Pra-OH 5, Fmoc-D-Pra-OH 6) afforded the desired resin bound peptides with alkyne functionalities at the side chains. The N-terminal amino acid of each peptide was then capped upon treatment with 20% acetic anhydride in pyridine. With the resin bound tripeptide bearing two propargylglycine side chains in hand, we conducted the on-resin CuAAC using the known N,N-bis(2-picolyl)(2-azidoethyl)amine 7 (11), copper(I) iodide and DIPEA to conjugate the two DPA moieties to the peptide backbone. For subsequent removal of the copper catalyst, the functionalised resin- bound peptide was thoroughly washed with a solution of the copper chelator sodium diethyldithiocarbamate trihydrate in DMF (12) . Cleavage of the peptide from the resin by treatment with a solution of trifluoroacetic acid/ triisopropylsilane/water (95:2.5:2.5, v/v/v), followed by purification on reversed-phase silica gel and complexation to stoichiometric amounts of zinc nitrate gave the triazole-containing receptors 1.Zn 2 and 2.Zn 2 in 25 and 22% yield, respectively, based on an initial resin loading of 0.55 mmol g −1 . The synthesis of aliphatic receptors 3.Zn 2 and 4.Zn 2 was carried out following our previously established method (7) which afforded receptors 3.Zn 2 and 4.Zn 2 in 32 and 29% yield, respectively, again based on an initial resin loading of 0.55 mmol g −1 .
Anion binding studies
The anion-binding abilities of receptors 1-4.Zn 2 were assessed utilising IDAs [6] with the previously used colorimetric indicator pyrocatechol violet 8 in Krebs buffer (pH 7.4, 25°C) (5) (6) (7) 13) . The association constants for the formation of the receptor-indicator complexes were determined by UV-vis titrations of solutions of indicator 8 (20 μM) with aliquots of solutions of receptors 1-4.Zn 2 (1000 μM) in Krebs buffer. In all cases, the addition of the receptor solution caused a decrease of the absorbance maximum at 446 nm, which was accompanied by an increase of the absorbance maximum at 646 nm ( Figure 3 ) and a naked-eye observable colour change of the indicator solution from yellow to blue upon the addition of one equiv. of receptor. Non-linear least square fitting of the titration data to a 1:1 binding model using the program HypSpec® (Hyperquad® package) (14) gave the apparent association constants (log K a ) for the receptor-indicator complexes ( Table 1 ). The 1:1 binding stoichiometry between receptors 1-4.Zn 2 and indicator 8 was corroborated by Job's plot analysis ( † ESI). Aliphatic receptors 3.Zn 2 and 4.Zn 2 which differed in the stereochemistry of the functionalised side chains displayed similar affinities for indicator 8 with log K a values of 6.5 and 6.3, respectively. Interestingly, the triazole-containing receptors 1.Zn 2 and 2.Zn 2 bound indicator 8 more strongly with log K a values of 7.2 and 7.0, respectively ( Table 1) .
We next performed anion screenings in Krebs buffer by preparing 1:1 receptor-indicator mixtures (20 μM each) and adding 10 equiv. of different anions (sodium salts) to assess which anions are able to displace indicator 8 from the receptor-indicator complex. The addition of PPi resulted in a distinct naked-eye observable colour change from blue to yellow indicating the successful displacement of 8. Minor colour changes were observed upon the addition of ATP and ADP suggesting partial indicator displacement, whereas no colour change was observed for other anions such as nitrate, sulfate, carbonate, chloride, bromide and iodide, or any of the other phosphoanions tested (Figure 4 ). To quantify the interaction of receptors 1-4.Zn 2 with PPi, ATP and ADP, we prepared a range of 1:1 receptor-indicator mixtures (20 μM) in Krebs buffer and titrated them with aliquots of solutions of the sodium salts of PPi, ATP and ADP (2000 μM) following the course of the titration by UVvis. In accordance with the previously observed colour changes, the addition of PPi induced an increase of the absorbance maximum at 446 nm which was accompanied by a significant decrease of the absorbance maximum at 646 nm ( Figure 5 ), whereas the addition of ATP and ADP induced considerably smaller changes in the absorbance spectra of the respective solutions ( Figure 6 ). From the titration data, the apparent association constants (log K a ) for the receptor-anion complexes were determined by a non-linear least squares fitting procedure based on the equilibria described for indicator displacement (15) using the HypSpec® (Hyperquad® package) software (14) and are summarised in Table 1 .
All receptors 1-4.Zn 2 exhibited strong binding to PPi (log K a ranging from 6.9 to 7.7) and clearly weaker 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 24, 30, 40 μM; inset: fitting curve for the titration data at 646 nm to a 1:1 binding model. binding to ATP and ADP (log K a ranging from 3.5 to 4.5) in Krebs buffer. The variation of the side chain stereochemistry had only minor effects on the anion-binding abilities of both the triazole-containing receptors and the aliphatic receptors. However, triazolecontaining receptors 1.Zn 2 and 2.Zn 2 bound PPi more strongly than aliphatic receptors 3.Zn 2 and 4.Zn 2 (log K a 7.7 and 7.6 vs. log K a 6.9 and 6.9) and ATP and ADP slightly stronger than the aliphatic receptors. The observation that the triazole-containing receptors did not only bind indicator 8, but also the tested phosphoanions with higher affinities than the aliphatic receptors enforced our initial hypothesis that the triazole linker alters the nature of the Zn(II)-DPA-binding pocket. We presumed that, in addition to the DPA nitrogen atoms, the triazole unit coordinates to the zinc centre, acting as a η 1 -ligand via the N 2 nitrogen atom, as was observed in a recent X-ray crystallographic study of a structurally similar Zn(II)-DPA-functionalised [1, 2, 3] -triazole compound conducted by Kuang et al. which shows that the DPA-functionalised triazole moiety can act as a tetradentate ligand for a Zn(II) ion (10) . For receptors 1.Zn 2 and 2.Zn 2 , evidence that the triazole units 2, 3, 5, 6, 8, 10, 12, 14, 16, 18, 25, 35, 51 μM; inset: fitting curve for the titration data at 646 nm to a 1:1 binding model. coordinate to the Zn(II) centres was provided by a comparison of the 1 H NMR spectra of 1 and 2 in the absence of and upon complexation with 2.0 equiv. of zinc nitrate (Figure 7) . The aromatic protons of the DPA ligands (denoted by black circles) exhibited downfield shifts of 0.3-0.5 ppm indicative of the successful complexation to Zn (II) (7) . Additionally, the aromatic proton of each of the two triazole linkers (denoted by black squares) is shifted downfield by 0.1-0.2 ppm, suggesting the interaction of the triazole units with the zinc centres. Gratifyingly, this change in the coordination environment of the zinc(II) centres lead to enhancements in binding affinities for anionic guests with the most significant enhancements observed for binding to PPi with the triazole containing receptors 1.Zn 2 and 2.Zn 2 exhibiting a six times stronger binding affinity to PPi than aliphatic receptors 3.Zn 2 and 4.Zn 2 .
Conclusions
In summary, we have synthesised and evaluated four linear peptide-based PPi receptors which were furnished with the bis-Zn(II)-DPA recognition motif. The installment of the Zn(II)-DPA binding sites was performed through the previously reported synthetic route using the RA reaction as well as through a novel synthetic route in which the attachment of the Zn(II)-DPA binding sites occurs via on-resin CuAAC. This approach introduces a [1, 2, 3] -triazole linker between the peptidic scaffold and the Zn(II)-DPA binding sites. Subsequent anion binding studies conducted in Krebs buffer showed that triazolecontaining receptors 1.Zn 2 and 2.Zn 2 exhibited stronger binding to PPi than aliphatic receptors 3.Zn 2 and 4.Zn 2 which was attributed to the presence of the [1, 2, 3] -triazole units linking the peptide backbone and the Zn(II)-DPA binding motif. Evidence was provided that the triazole moieties coordinate to the zinc centres of the Zn(II)-DPA ligands and thus, presumably induce a higher degree of receptor preorganisation which is responsible for the enhanced PPi binding affinity. Future work will focus on the development of rigid cyclic peptide based analogues equipped with the triazole-altered Zn(II)-DPA motifs as we envisage the combination of the rigid peptide scaffold and the preorganised triazole Zn(II)-DPA binding motif will afford highly complementary PPi receptors.
Experimental
General information
All chemicals and solvents were of reagent grade and used as received unless otherwise noted. Fmoc-Pra-OH was synthesised by Boc deprotection of Boc-Pra-OH and subsequent Fmoc protection using Fmoc-OSu. Melting points were manually observed using a Stanford Research Systems Optimelt melting point apparatus and are uncorrected. Optical rotations were obtained using a Perkin Elmer Model 341 polarimeter at 589 nm and 20°C, using the indicated spectroscopic grade solvents. 1 H NMR spectra were recorded using a Bruker Avance III 500 at a frequency of 500.13 MHz or a Bruker Avance DPX 400 at a frequency of 400.13 MHz and are reported as parts per million (ppm) with CD 3 OD (δ H 3.31 ppm) as an internal reference. The data are reported as chemical shift (δ), multiplicity (br = broad, s = singlet, d = doublet, t = triplet, m = multiplet), coupling constant (J Hz) and relative integral. 13 C NMR spectra were recorded using a Bruker Avance III 500 at a frequency of 125.76 MHz or a Bruker Avance DPX 400 at a frequency of 100.61 MHz and are reported as parts per million (ppm) with CD 3 OD (δ C 49.00 ppm) as an internal reference. Low-resolution mass spectra were recorded on a Thermo Finnigan LCQ Deca Ion Trap mass spectrometer using electrospray ionisation (ESI, positive mode) and are reported as m/z (relative intensity). High-resolution ESI spectra were recorded on a Bruker BioApex Fourier transform ion cyclotron resonance mass spectrometer (FTICR) with an Analytica ESI source, operating at 4.7 T or a Bruker Daltonics Apex Ultra FTICR with an Apollo Dual source, operating at 7 T and are reported as m/z (relative intensity). Infrared absorption spectra were recorded on a Bruker Alpha-E FT-IR spectrometer using attenuated total reflection (ATR) of either a solid or a thin film. Notable vibrational wavenumbers are recorded in cm −1 . UV-vis data were recorded using a Varian Cary 4000 UV-vis spectrophotometer at 25°C. Temperature control was provided by a Varian Cary PCB 150 Water Peltier System. pH values were obtained using an Activon Model 209 pH per mV meter. Reversed-phase column chromatography was performed on a Biotage Isolera Prime automated flash purification system equipped with a dual-wavelength UV-vis detector. The detection wavelengths were 254 and 280 nm, respectively. Molecular structures were modelled employing molecular mechanic force field (MMFF) calculations and MMFF structures were fully optimised using DFT calculations at the B3LYP/6-31G * level of theory (Spartan'10).
General procedures for Fmoc-SPPS of 1-4.Zn 2
Resin loading
Rink amide resin (loading 0.55 mmol g −1 ) was swollen in DMF for 1 h. The resin was drained and washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5). The resin was then treated with 20 vol% piperidine in DMF (3 × 5 min) for Fmoc deprotection and washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5). A solution of Fmoc-Gly-OH (3 equiv.), PyBOP (3 equiv.) and DIPEA (6 equiv.) in DMF was added to the resin. The suspension was agitated at rt for 2 h and then washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5).
N-terminal Fmoc deprotection
The resin-bound peptide was treated with 20 vol% piperidine in DMF (3 × 10 min) for Fmoc deprotection and washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5). The resulting free amine was immediately subjected to the following coupling step.
Estimation of resin loading
The drained Fmoc deprotection solution was diluted with a solution of 20 vol% piperidine in DMF so that the maximum concentration of the fulvene-piperidine adduct was in the range of 2.5-7.5 × 10 −5 M. A sample of this solution (2 × 3 mL) was transferred to two matched 1cm quartz glass cuvettes and the UV-vis absorbance at 301 nm was measured, using the solution of 20 vol% piperidine in DMF as a reference. An average of the two absorbance values was used to calculate the loading, using ε = 7800 M −1 cm −1 .
Amino acid coupling
A solution of the respective amino acid (2.5-3 equiv.), PyBOP (2.5-3 equiv.) and DIPEA (5-6 equiv.) in DMF was added to the resin. The suspension was agitated at RT for 2 h and then washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5).
Acetylation
After coupling of the final amino acid, the Fmoc protecting group was removed. The free amine functionality was acetylated by treatment with 20 vol% acetic anhydride in pyridine (3 × 5 min) and washed with DMF (×5), CH 2 Cl 2 (×5) and DMF (×5).
Copper(I)-catalysed azide-alkyne [3 + 2] cycloaddition
The resin was swollen in DMF at RT for 1 h before a solution of DIPEA (3 equiv.), copper(I) iodide (3 equiv.) and N,N-bis(2-picolyl)(2-azidoethyl)amine (4 equiv.) in DMF was added to the resin. The resulting suspension was agitated at RT for 2 days and the reaction progress was monitored by LCMS. The resin was rinsed and washed with CH 2 Cl 2 (×5), a solution of sodium diethyldithiocarbamate trihydrate (20 mg mL −1 ) with 1 vol% triethylamine in DMF (×10), DMF with 1 vol% triethylamine (×5), DMF (×5) and CH 2 Cl 2 (×5) and dried in vacuo overnight.
(Allyloxy)carbonyl (Alloc) deprotection
The resin was swollen in CH 2 Cl 2 at RT for 1 h prior to the deprotection step. The resin was agitated in a solution of Pd(PPh 3 ) 4 (0.8 equiv.) and phenylsilane (25 equiv.) in CH 2 Cl 2 (2 × 1 h). The resin was rinsed and washed with CH 2 Cl 2 (×5), a solution of sodium diethyldithiocarbamate trihydrate (20 mg mL −1 ) with 1 vol% triethylamine in DMF (×10), DMF with 1 vol% triethylamine (×5), DMF (×5) and CH 2 Cl 2 (×5) and dried in vacuo overnight.
Reductive amination
The resin was swollen in DMF at RT for 1 h before being treated with 2-pyridinecarboxaldehyde (20 equiv.) with 1 vol% AcOH in DMF (5 mL) and agitated at RT overnight. The resin was rinsed and washed with DMF (×3). A suspension of sodium triacetoxyborohydride (25 equiv.) and 2-pyridinecarboxaldehyde (20 equiv.) with 1 vol% AcOH in DMF (5 mL) was added to the resin and the resulting suspension was agitated at RT overnight. The resin was rinsed and washed with MeOH (3 × 5 mL), DMF (×5), CH 2 Cl 2 (×5) and DMF (×5) and dried in vacuo overnight.
Cleavage of peptides from resin
The resin was treated with a solution of trifluoroacetic acid/H 2 O/triisopropylsilane (95:2.5:2.5, v/v/v) for 1 h. The resin was drained and then washed with trifluoroacetic acid (×3). The cleavage solution and acid washes were combined and the solvent evaporated.
Purification
Peptides were purified by reversed-phase column chromatography (25 g C 8 -reversed phase silica gel; water/ CH 3 CN with 1 vol% ammonium hydroxide solution (25%), 0-50% CH 3 CN, 75 mL min −1 ). Appropriate fractions were lyophilised, affording the pure peptides as colourless solids.
Complexation to zinc
A solution of peptide in MeOH (10 mg mL −1 ) was added to an aqueous solution of Zn(NO 3 ) 2 ·4H 2 O (2 equiv. relative to peptide, 10 mg mL −1 ) and the mixture was stirred at RT for 1 h. The mixture was concentrated and the residue lyophilised, affording the bis[Zn(II)] complex as a nitrate salt.
Synthesis
Receptor 1.Zn 2
Tripeptide 1 was synthesised on Rink amide resin (0.311 g, resin capacity 0.55 mmol g −1 ), utilising the above general methods. Yield: 36.0 mg (25%);
[α] D 20 = −20.4 (c 0.70 MeOH); 1 H NMR (500 MHz, MeOD) δ 8.41 (m, 4H), 7.70-7.77 (m, 6H), 7.26 (m, 8H), 4.61 (m, 2H), 4.49 (m, 4H), 3.80-3.90 (m, 10H), 3.28-3.32 (m, 1H), 3.17 (m, 2H) , 3.01 (m, 5H), 1.90 (s, 3H) ,NH signals not observed; 13 C NMR (75 MHz, MeOD) δ 174.5, 173.5, 173.3, 173.2, 160.1, 160.0, 149.4, 149.3, 144.2, 143.9, 138.8, 138.7, 125.2, 125.1, 124.8, 123.9, 60.6, 54.9, 54.8, 54.6, 43.3, 28.6, 28.3, 22.5 ; IR (ATR) ν max 3275, 3061, 2931, 2830, 1654, 1591, 1534, 1475, 1433, 1370, 1224, 1148, 1130 8.10 (m, 4H), J = 18 Hz, 2H), 7.64 (m, 8H), 4.65 (1H), 4.49 (m, 9H), 4H) 4, 173.8, 173.7, 173.2, 160.0, 159.9, 149.5, 149.4, 144.3, 143.9, 138.7, 138.6, 125.1, 125.0, 124.8, 124.7, 123.9, 123.8, 60.7, 55.0, 54.9, 54.8, 43.4, 28.4, 28.1, 22.6 ; IR (ATR) ν max 3290, 3055, 2921, 2831, 1651, 1588, 1528, 1478, 1433, 1363, 1210, 1122 8.11 (t, J = 7.6 Hz, 4H), 2H), 7.66 (m, 8H), 4.64 (m, 1H), 4.46 (m, 9H), 4H) 9, 174.6, 174.2, 173.6, 160.7, 149.4, 138.7, 138.6, 124.9, 123.8, 61.1, 61.0, 55.4, 55.3, 55.2, 55.0, 32.8, 32.1, 27.7, 27.6, 24.7, 22.5 ; IR (ATR) ν max 3269, 3077, 2942, 2868, 1650, 1607, 1537, 1442, 1367, 1306, 1199, 1157, 1103 7, 174.6, 174.4, 173.8, 160.5, 160.4, 149.4, 149.3, 138.7, 138.6, 124.8, 123.8, 61.00, 60.9, 55.6, 55.4, 55.3, 43.2, 32.2, 31.9, 27.5, 27.4, 24.8, 24.6, 22.3 ; IR (ATR) ν max 3272, 3056, 2933, 2861, 1650, 1591, 1540, 1433, 1371, 1300, 1200, 1148, 1093 
Anion binding studies
All measurements were performed in Krebs buffer or artificial urine 25 at pH 7.4 and at 25°C.
General procedure for titrating indicator 8 with receptors 1-4.Zn 2 : To a 1-cm quartz glass cuvette was added a solution of the indicator PV (2.5 mL, 20 μM) and to another matched quartz glass cuvette was added the buffer solution as the blank (2.5 mL). The absorbance spectrum was recorded from 250 to 750 nm. Aliquots of a solution containing the respective receptor (1000 μM) were then added to both the sample and the blank cuvettes. After each addition, the resulting solution was stirred for at least 30 s before the absorbance spectrum was recorded. Typically, up to 10 equiv. of the receptor were added to the solution. All titrations were repeated three times. To determine association constants for the receptor-indicator complexes, global analysis of the absorbance data over the range of 300-720 nm was carried out using a non-linear least squares curve fitting procedure, based on the equilibria described for 1:1 binding, using the commercially available software program Hyp-Spec® (Hyperquad® package).
General procedure for titrating receptor-indicator ensembles with anions: stock solutions of the respective 1:1-receptor:indicator 8 ensemble (20 μM both) and of the tested phosphoanions as sodium salts (2000 μM) were prepared. To a 1-cm quartz glass cuvette was added a solution of the receptor-indicator ensemble (2.5 mL) and to another matched quartz glass cuvette was added a solution of the same concentration of the receptor as the blank (2.5 mL). The absorbance spectrum was recorded from 250 to 750 nm. Aliquots of the respective anion solution were then added to both the sample and the blank cuvettes. After each addition, the resulting solution was stirred for at least 30 s before the absorbance spectrum was recorded. Typically, up to 10 equiv. of the anion were added to the solution. All titrations were repeated three times. To determine association constants for the receptor-anion complexes, global analysis of the absorbance data over the range of 300-720 nm was carried out using a non-linear least square curve fitting procedure, based on the equilibria described for indicator displacement, using the commercially available software program HypSpec® (Hyperquad® package).
Supplementary material
Copies of 1 H and 13 C NMR spectra for all new compounds and anion titration data are available online here: http://dx. doi.org /10.1080/10610278.2015.1122789 
